Setting Standards for Immunosequencing
Adaptive Biotechnologies™ is the pioneer in combining high-throughput sequencing and expert bioinformatics
to profile T-cell and B-cell receptors.
We bring the accuracy and sensitivity of the immunoSEQ™ Platform into laboratories around the world to drive
groundbreaking research. We are also committed to translating our immunosequencing discoveries into clinical
diagnostics to improve patient care in cancer and other immune-mediated diseases.
